Patrick Fadden, PhD

Patrick Fadden, PhD

Research Director

Patrick provides scientific support for clients around model selection and study design at the Charles River Oncology Pharmacology site in North Carolina. In addition, he leads the site’s internal syngeneic model research and development team. Dr. Fadden is a protein biochemist by trade and spent over a decade leading oncology drug discovery project teams and working on clinical development.

Dr. Fadden has a PhD in physiology from the University of Virginia, has been featured in 20 publications, and holds three patents.